Introduction
Current research has estimated that approximately 371 million people worldwide suffer from diabetes, some 90% of these cases are type 2 diabetes (T2D). The number of diagnosed diabetes cases has doubled since 1980 due to the aging population and the rising incidence of risk factors, such as obesity. 1 Cardiovascular diseases, which include heart failure, are the leading cause of morbidity and mortality in T2D patients. Of these T2D patients, about two-thirds die from heart failure. 2, 3 Diabetes increases the risk of developing diabetic cardiomyopathy. [3] [4] [5] Diabetic cardiomyopathy is a disease that damages the structure and function of the heart resulting in cardiac metabolic changes, hypertrophic growth, myocardial fibrosis and arrhythmias, which eventually cause heart failure. 6, 7 The molecular mechanism of this linkage between obesitydiabetes-cardiomyopathy is not well understood. In light of the growing and wide-spread incidence of T2D and obesity in modern society, this is a major research challenge that can help to improve public health.
The heart meets its energy requirements via the oxidation of fatty acids, glucose, lactate and other oxidizable substrates. The heart functions best when both fatty acids (70%) and glucose (30%) are simultaneously used as substrates for ATP production. 6 Increased fatty acid levels in the blood promote the production of hormones and inflammatory cytokines by adipocytes resulting in whole-body insulin resistance. 8 Under these conditions, the heart rapidly adapts by consuming primarily fatty acids as a source of ATP generation. Despite an increase in fatty acid metabolism, it is likely that fatty acid uptake exceeds oxidation rates, thereby resulting in cellular lipid accumulation-induced lipotoxicity. 5, 9, 10 At the molecular level, insulin signalling activates multiple pathways targeting various transcription factors resulting in re-programing of adaptive or maladaptive cardiac remodeling processes. 11 In this report, we identify an important transcription factor that plays a major role in this process: Activating Transcription Factor 3 (ATF3). ATF3 is a member of the basic leucine zipper (bZIP) superfamily of transcription factors and is encoded by an immediate early gene whose expression is low under normal condition but is rapidly and highly induced by multiple stressors. 12 ATF3 binds to the cyclic AMP response element (CRE) and typically dampens the expression of multiple target genes. Depending on the context, ATF3-mediated response can be adaptive or maladaptive. 12, 13 For example, the role of ATF3 in cardiac diseases varies depending on the stress paradigms. Neuroendocrine hormones stimuli induce ATF3 transcription both in vitro 14 and in vivo. 15 Mice with ATF3 deficiency display reduced cardiac remodeling and hypertrophy in a phenylephrineinduced pressure overload model. 16, 17 Consistently, ectopic ATF3 expression in cardiomyocytes is sufficient to promote heart growth and cardiac dysfunction in transgenic mice. 16, 18 Together, this suggests a deleterious role of ATF3 in cardiac diseases. In contrast, studies using ATF3 deficient mice in the context of transverse aortic constriction suggest a cardiac protective role for ATF3. 19, 20 Thus, the importance of ATF3 in cardiac remodeling models is well documented, but its effects vary depending on the stress paradigms. [21] [22] [23] [24] In addition to cardiac diseases, ATF3 has been shown to play a role in other diseases, including diabetes. Previously, we showed that mice deficient in ATF3 had reduced glucose tolerance and more severe T2D than the wild type mice under a high-fat diet (HFD). 25 We investigated ATF3 in this context, since ATF3 is known to be induced by stresses that play a role in obesity-induced T2D cardiomyopathy, including metabolic stress, oxidative stress, endoplasmic reticulum (ER) stress and inflammation. 12, 26 However, the role of ATF3 in diabetes-induced cardiomyopathy has never been reported. In this article, we set out to test whether cardiomyocytes-selective deletion of ATF3 alters HFD-induced T2D cardiomyopathy. We present evidence that following a HFD, cardiac ATF3 deficiency exacerbates cardiac remodeling, inflammation, maladaptive metabolic response, and cardiac dysfunction. Surprisingly, it also worsens blood glucose intolerance, including a reduced ability of the peripheral tissues to respond to insulin. Since ATF3 deletion is selectively in cardiomyocytes-which is not a cell type known to play a role in diabetes-this result is novel and intriguing.
Methods

Mice
This study was carried out in strict accordance with the Guide for the Care and Use of Laboratory Animals of the National Institute of Health. In addition, our protocol was approved by the Committee of the Ethics of Animal Experiments of the Technion. All mice strains used in this study were backcrossed to C57Bl/6J for at least six generations. Mice strains used in this study: whole-body ATF3 KO (ATF3-KO), 27 ATF3-
, aMHC-Cre 29 and loxP-XFP transgenic (confetti) mice. 30 To generate mice with a cardiomyocyte-specific deletion of ATF3 (ATF3-cKO), we crossed mice carrying ATF3-flox alleles with transgenic mice harbouring Cre recombinase driven by a aMHC promoter. Mating cages were set up to produce progeny with only one copy of aMHCCre to avoid variability in Cre expression. 31 ATF3 f/f and ATF3-cKO male mice littermates were housed in the same cage, on a 12-h light/dark cycle and given ad libitum access to food and water. All experimental groups were fed with normal chow (NC; 4.4% fat) for 10 weeks. Subsequently, mice were either left on the NC diet or switched to high-fat diet (HFD; 60% fat; TD.06414 Harlan Inc.) for additional 15 weeks.
Glucose tolerance test, fasting glucose test, and blood biochemistry
The mice fasted for 6 h and were then intraperitoneally injected with 2 g/kg of glucose. Blood samples were obtained from their snipped tail and analysed using a portable glucometer. Blood from non-fasting mice was collected from submandibular bleeds and serum insulin levels were measured by ELISA (Merck Millipore). Total cholesterol and high density lipoprotein (HDL) cholesterol were measured at the Rambam Clinical Biochemistry Laboratory.
Insulin signalling
For insulin signalling analysis, HFD-fed ATF3 f/f and ATF3-cKO mice fasted for 6 h and were then intraperitoneally injected with insulin (10 U/ kg; Lantus SoloStar, Sanofi-Aventis, NJ). Mice were euthanized by an injection of 0.1 mL of 12 mg/mL Xylazine 60 mg/mL Ketamine mixture. Heart, liver, and skeletal muscle (gastrocnemius) were harvested 15 min following insulin stimulation. Tissue lysates were then prepared.
Echocardiography
Mice were anesthetized with 1% of isoflurane and kept on a 37 C heated plate throughout the analysis. An echocardiography was performed using a Vevo2100 micro-ultrasound imaging system (VisualSonics, Fujifilm) which was equipped with 13-38 MHz (MS 400) and 22-55 MHz (MS550D) linear array transducers. The person performing echocardiography and the data analysis was blinded to the mice genotype. Cardiac size, shape, and function were analysed by conventional two-dimensional imaging and M-Mode recordings. Maximal left ventricles end-diastolic (LVDd) and end-systolic (LVDs) dimensions were measured in short-axis M-mode images. Fractional shortening (FS) was calculated as FS (%) = [(LVDd-LVDs)/LVDd]Â100. All values were based on the average of at least five measurements.
MRI hardware and animal monitoring
MRI was performed on a 9.4T bore scanner (Bruker Biospec, Ettlingen, Germany), using a cylindrical volume coil (86 mm inner diameter) for signal excitation and a single channel surface coil (20 mm diameter) for signal reception. The animal was put under anaesthesia, with a concentration of 0.5-1.5% isoflurane, and supplemented with oxygen (0.5 L/min). Respiration was monitored during imaging (Small Animal Instruments, Stony Brook, New York, NY) and body temperature was maintained using thermostat-regulated circulating hot water.
Cardiac magnetic resonance (CMR) sequences
The mice were scanned using cine FLASH sequence, acquired from the self-gating technique IntraGate (Bruker BioSpin MRI, Ettlingen, Germany The total acquisition time for each animal was $40 min.
MRI image analysis
Image analysis was performed using the freely available Segment software (Medviso AB, Lund, Sweden). 32 Manual segmentation of the endocardium and epicardium of the LV was performed to measure LV mass and LV functional parameters-end-systolic and end-diastolic (ESV and EDV respectively) volumes. Ejection fraction (EF) was calculated as EF (%) = [(EDV-ESV)/EDV]Â100. The person performing the MRI and the data analysis was blinded to the mice genotype.
Heart harvesting
At endpoint, mice were anesthetized, weighed and sacrificed. Hearts were excised and ventricles were then divided into three pieces that were used for protein extraction, RNA purification and histological analysis.
mRNA extraction
mRNA was purified from ventricles using an Aurum total RNA fatty or fibrous tissue kit (#732-6830, Bio-Rad) or from isolated cardiomyocytes using a High Pure RNA Isolation kit (#11828665001 Roche Diagnostics) according to the manufacturer's instructions.
Quantitative real-time PCR (RTqPCR)
cDNA was synthesized from 800 or 50 ng of purified mRNA derived from the ventricles or isolated from the cardiomyocytes, respectively. Purified mRNA was added to a total reaction mix of high-capacity cDNA reverse transcription kit (#4368814, Applied Biosystems) in a final volume of 20 mL. Real-time PCR was performed using Rotor-Gene 6000TM (Corbett) equipment with absolute blue SYBER green ROX mix (Thermo Scientific AB-4162/B). Serial dilutions of a standard sample were included for each gene to generate a standard curve. Values were normalized to b2 microglobulin expression levels. The primer sequences are shown in Table S1 (see Supplementary material online).
Western-blot analysis
Harvested tissues were homogenized in RIPA buffer (PBS containing 1% NP-40, 5 mg/mL Na-deoxycholate, 0.1% SDS) and supplemented with protease inhibitor cocktail (P-8340, Sigma-Aldrich). Homogenization was performed at 4 C using the Bullet Blender homogenizer (BBX24;
Next advance) according to the manufacturer's instructions as previously described. 17 
Immunohistochemistry
Tissues were fixed in 4% formaldehyde overnight, then embedded in paraffin, serially sectioned at 10 lm intervals, and then mounted on slides. Sections were processed for deparaffinization (xylene, 20 min), dehydration (isopropanol), rehydration (H 2 O) and antigen unmasking (10 mM sodium citrate pH-6, 90 C, 12 min). Immunostaining was performed using Histostain kit (#959643, Invitrogen) according to the manufacturer's instructions. Anti-ATF3 antibodies were diluted 1:50. Following immunostaining, nuclei were stained with hematoxylin.
Antibodies
The primary antibodies used: anti-SMA (Cat# A2547), anti-a-tubulin (Cat # T-9026) and anti-a-actinin (Cat# A7811) which were all purchased from Sigma-Aldrich. Anti-GFP (SC-8334) was purchased from Santa-Cruz. Anti-p38 (Cat# 9212) and anti-phospho-p38 (Cat# 9211) were purchased from Cell signalling. Anti-pAkt (Cat# AF887) and antiAkt (Cat# MAB 2055) was purchased from R&D Systems, anti-Foxo3 (Cat# 07-1719) was purchased from Merck Millipore, and anti-Glut4 (Cat# ab654) was purchased from Abcam. Lastly, anti-ATF3 antibody was generated in Aronheim's lab. 15 
Cell size analysis
Sections were stained following deparaffinization with Wheat-germ agglutinin TRITC-conjugated (Sigma-Aldrich Cat# L5266) and diluted to a 1:100 phosphate-buffered saline (PBS). Sections were washed 3 times with PBS and mounted in Fluoromount-G (Southern Biotechnology, Birmingham, AL, 0100-01). Sections were then viewed using a Zeiss LSM700 confocal microscope (Thornwood, NY) equipped with a 40Â oil objective and solid state 555nm laser. Quantification of the cell size was performed with Image Pro Plus software. Five fields in each slide were photographed. Unstained areas were then identified and segmented using Image Pro Plus software. In each stained area, the mean cell perimeter and area was calculated, and the number of cells was measured.
Fibrosis staining
Heart tissue was fixed in 4% formaldehyde overnight, embedded in paraffin, serially sectioned at 10 mm intervals, and then mounted on slides. Masson's trichrome staining was performed according to the standard protocol. Images were acquired by using Virtual Microscopy (Olympus). Stained areas were segmented and quantified following calibration using Image Pro Plus software. Five fields were quantified for each slide.
In vitro cardiomyocyte culture
Adult cardiomyocytes were isolated from 12-to 25-week-old NC-or HFD-fed mice by a modified Langendorff perfusion apparatus as described. 33 Isolated cells were plated in culture media (MEM-Eagle
Hanks' salts) supplemented with penicillin 100 U/mL, glutamine 2 mM, NaHCO 3 4 mM, HEPES 10 mM, bovine serum albumin (BSA) 0.2%, 25 mM blebbistatin (cat # B0560, Sigma-Aldrich) and 5% foetal bovine serum. Cardiomyocytes were then plated on 35-mm dishes, coated with mouse laminin (#L2020, Sigma-Aldrich) at a density of 10 5 cells/mL in serum free medium. 
Palmitate-treated cardiomyocytes
Forty-five minutes after plating, the medium was replaced with a culture medium containing either 0.4 mM palmitate or BSA (control). Palmitate stock solution (20 mM) was diluted in 0.01 M NaOH by heating at 70 C for 30 min as described. 10 Following overnight culture, conditioned medium was collected and cardiomyocytes were harvested for RNA extraction. In addition, overnight palmitate-or BSA-treated cardiomyocytes were incubated with 100 nM insulin (I-5500, Sigma-Aldrich) for 30 min, and were then harvested for protein extraction.
Enzyme-linked immuno-absorbent assay
Interleukin 6 (IL-6) and tumour necrosis factor a (TNFa) levels in conditioned medium from an overnight culture of primary cardiomyocytes were measured by ELISA using the DuoSet ELISA kit (R&D Systems) according to the manufacturer's instructions. Blood from non-fasting HFD-fed mice was collected from submandibular bleeds, and serum IL-6 and TNFa levels were measured by ELISA (R&D Systems).
Statistics
Our data is expressed as means ± SD. The statistical test for the GTT was performed by repeated-measures analysis of variance (ANOVA).
The comparison of two means was analysed by the Student's t-test. The comparison between several means was analysed by one-way ANOVA followed by Tukey's post hoc analysis. All statistical analyses were performed using GraphPad Prism 5 software (La Jolla, CA). A P value < _ 0.05 was accepted as statistically significant.
Results
aMHC promoter specificity
First, we verified the tissue specific expression of the Cre recombinase under the control of the aMHC promoter, by crossing aMHC-Cre mouse with the loxP-XFP transgenic (confetti) mouse. 30 In the confetti mouse, lox-P specific recombination resulted in the random expression of one out of four fluorescent proteins (BFP, GFP, RFP or YFP). Cell lysates were prepared from various tissues of either the confetti f/f mouse (without Cre, -) or the double transgenic mouse (containing Cre, 1) followed by western-blot analysis using anti-GFP antibodies. As expected, GFP-related proteins were strongly detected in the heart lysate (see Supplementary material online, Figure S1 ). The lysate derived from lung tissue displayed a lower level of GFP-related proteins as compared to the heart lysate, probably due to low transcription activity of the aMHC promoter in the lungs. 34 GFP-related protein expression was undetectable in all of the other tissues tested (see Supplementary material online, Figure S1 ).
In vitro analysis of cardiomyocytes treated with free fatty acids
To reveal the possible role of ATF3 in cardiomyopathy induced by free fatty acids (FFA) (palmitate), we analysed adult cardiomyocyte primary cultures derived from ATF3 f/f and ATF3-cKO mice (ATF3-cKO, genotype ATF3
f/f /aMHC-Cre). Cardiomyocytes were isolated by the Langendorff perfusion apparatus followed by overnight treatment with 0.4 mM palmitate. 10 qRT-PCR analysis showed a 4-to 5-fold increase in ATF3 induction by palmitate in the ATF3 f/f cardiomyocytes ( Figure 1A) .
Immuno-fluorescence analysis of cardiomyocytes treated with either 1 h or overnight palmitate displayed a robust ATF3 nuclear staining ( Figure  1B) . Consistent with a previous study, 35 western-blot analysis of the cardiomyocytes lysate following overnight palmitate treatment demonstrated a significant induction of the ATF3 protein ( Figure 1C) . Since ATF3 induction is dependent on the activation of the p38-MAPK signalling pathway, 10, 26 we measured the p38-MAPK (p38) activation state using anti-phospho-p38 (p-p38). While p-p38 levels were increased following palmitate treatment, p38 remained unchanged independent of the treatment ( Figure 1C) . As expected, neither ATF3 transcript ( Figure  1A ) nor ATF3 protein ( Figure 1C) was detected in the palmitate-treated ATF3-cKO cardiomyocytes. Importantly, palmitate treatment induced the expression of cardiac hypertrophic markers (ANP and BNP), inflammation markers (IL-6 and TNFa), a metabolic marker (PDK4) and an extracellular matrix (ECM) remodeling protein (TIMP1) ( Figure 1A) . Strikingly significantly higher level of induction of these genes was observed in the ATF3-cKO cardiomyocytes as compared with ATF3
f/f cardiomyocytes ( Figure 1A) . In addition, while the expression level of the insulin receptor substrate, IRS1, was induced 2-fold by palmitate treatment in ATF3
f/f , IRS1 expression was suppressed in ATF3-cKO cardiomyocytes ( Figure 1A) . Next, we quantified the level of secreted inflammatory cytokines by analysing the conditioned medium derived from palmitate-treated cardiomyocytes. The levels of IL-6 and TNFa were significantly higher in the conditioned medium derived from palmitate-treated ATF3-cKO cardiomyocytes as compared to their conditioned media levels derived from palmitate-treated ATF3 f/f cardiomyocytes ( Figure 1D) .
Collectively, the above-mentioned results support an increase of ATF3 expression in cardiomyocytes in response to acute and chronic exposure to FFA. The analysis of cardiomyocytes derived from wild type and ATF3-cKO genotypes in vitro is consistent with a possible protective role of ATF3 by dampening the cardiomyocytes remodeling response to FFA.
The effect of high-fat diet on wild type and ATF3-cKO mice
To determine whether cardiac ATF3 expression plays a role in response to a high-fat diet (HFD)-regimen, we used mice harbouring a cardiomyocyte-selective deletion, ATF3-cKO, and their wild type (ATF3 f/ f ) counterparts. Mice were fed either a normal chow (NC, 4.4% fat) or a HFD (60% fat). The HFD was initiated at 10 weeks of age and continued for 15 weeks. Both ATF3 f/f and ATF3-cKO mice fed with a HFD gained weight at significantly higher rates than NC-fed mice, with no significant differences between the genotypes (see Supplementary material online, Figure S2 ). In addition, the levels of circulating total cholesterol, and high density lipoprotein (HDL) were significantly higher in HFD-fed mice in comparison to NC-fed mice, with no significant difference between the genotypes (see Supplementary material online, Figure S3A and B).
Cardiomyocyte-selective ATF3 deficiency induces cardiac remodeling
Since ATF3 is highly induced in cardiomyocytes that are treated with FFA (0.4 mM palmitate), we studied the expression of ATF3 in heart tissue following 15 weeks of a HFD regimen by qRT-PCR. ATF3 expression was induced 6-fold in the hearts of HFD-fed ATF3 f/f mice when compared to either the NC-fed mice or to HFD-fed ATF3-cKO ( Figure  2A) . We next performed immuno-histochemistry staining of heart slices derived from NC-and HFD-fed mice with anti-ATF3 antibodies. While no ATF3 staining was observed in the hearts derived from NC-fed mice or HFD-fed ATF3-cKO mice, efficient ATF3 nuclear staining was observed in HFD-fed ATF3 f/f mice ( Figure 2B ).
In addition, western-blot analysis using anti-ATF3 antibodies with cardiomyocyte cell lysate confirmed a high level of ATF3 protein expression in HFD-fed as compared with NC-fed mice ( Figure 2C and D) . We next examined the cardiac expression levels of various gene specific markers as an indication for cardiac remodeling processes of a stressed heart. HFD-fed ATF3-cKO but not ATF3 f/f mice exhibited significantly higher levels of the foetal gene programming markers (ANP, BNP and bMHC) when compared to the NC-fed wild type counterparts (Figure 2A) . Concomitantly, a-myosin heavy chain (aMHC) expression was significantly reduced in HFD-fed mice as compared to NC-fed mice independent of their genotype (Figure 2A) . The switch from aMHC to bMHC is an indication of the cardiac remodeling process as well as a cardiac disease state. Heart sections stained with wheat-germ hemagglutinin revealed a significant increase in the cross sectional area in HFD-fed mice with larger increased area in ATF3-cKO mice as compared with ATF3 f/f mice ( Figure 2E and F) . Taken together, cardiac remodeling induced by a HFD is more pronounced in the ATF3-cKO mice than that in the control ATF3 f/f mice.
We next examined fibrosis markers and found elevated expression of collagen 1a, cTGF, and a-SMA in HFD-fed mice as compared to the corresponding NC-fed mice ( Figure 3A) . In all cases, the ATF3-cKO mice showed a more pronounced phenotype ( Figure 3A) . Western-blot analysis with cell lysates derived from both NC-fed and HFD-fed mice confirmed increased levels of a-SMA in HFD-fed mice, but these high levels were more noticeable in the lysate derived from HFD-fed ATF3-cKO mice ( Figure 3B and C) . Another fibrosis marker, TGFb3 is significantly elevated 
in ATF3-cKO mice, but not in the control ATF3 f/f mice ( Figure 3A) , again indicating that HFD has a more profound effect on ATF3-cKO mice. We next examined fibrosis histologically by Masson's trichrome staining. This analysis confirmed a significant increased fibrosis in the hearts of HFD-fed mice, with ATF3-cKO mice exhibiting the highest fibrosis level ( Figure 3D and E) . Fibrosis is a result of the deposition of collagen in the ECM. The net effect of ECM degrading enzymes such as metalloproteinases (MMPs) and their inhibitors (TIMPs) determines the level of collagen deposition. 36 The levels of MMP9 were significantly decreased in HFD-fed mice as compared to NC-fed mice independent of the mice genotype ( Figure 3A) . In contrast, TIMP1 levels were significantly increased in HFD-fed mice, with considerably higher levels in the ATF3-cKO mice, consistent with the finding that ATF3-cKO mice display higher level of fibrosis ( Figure 3A) . Cardiac remodeling processes and diabetes are typically associated with increased inflammation. We therefore measured several inflammatory markers in the hearts of NC-and HFD-fed ATF3
f/f and ATF3-cKO mice. IL-6 expression was highly induced in the hearts of NC-and HFDfed ATF3-cKO mice as compared with ATF3 f/f mice. Significantly, HFDfed ATF3-cKO mice displayed the highest level ( Figure 4A) . Similarly, TNFa was expressed at significantly higher levels in HFD-fed ATF3-cKO mice ( Figure 4A) . To identify the source of IL-6 and TNFa expression, we have isolated cardiomyocytes from mice fed with HFD for 15 weeks and examined the cytokine's transcription and secretion levels by both qRT-PCR and ELISA, respectively. Indeed, the transcription ( Figure 4B ) and secretion ( Figure 4C ) levels of IL-6 and TNFa were significantly higher in cardiomyocytes derived from HFD-fed ATF3-cKO mice as compared to their ATF3 f/f cardiomyocytes counterparts. To reveal whether the inflammatory response in the heart following a HFD affects circulating IL-6 and TNFa levels, we measured the cytokines in the serum of HFDfed mice using ELISA. Indeed, a significant increase in IL-6 and TNFa levels were detected in the serum of ATF3-cKO mice ( Figure 4D and E, respectively). Collectively, we conclude that cardiomyocytes are the cells responsible, at least in part, for the expression and secretion of IL-6 and TNFa in HFD-fed mice, with significantly higher circulating levels in ATF3 deficient mice. Lastly, since inflammation is often associated with a maladaptive metabolic response, we analysed the expression levels of various metabolic genes in the heart. The level of IRS1, a gene involved in insulin signalling, was significantly reduced in HFD-fed mice. The reduction was more pronounced in the ATF3-cKO than in control mice ( Figure 5A) . Similarly, the level of fatty acid translocase (CD36) was significantly higher in HFD-fed ATF3 f/f mice. IRS2 was much higher in the NC-fed ATF3-cKO mice than in the control counterparts (NC-fed ATF3 f/f mice), consistent with our previous data that its gene expression is suppressed by ATF3. 37 Interestingly, IRS2 is induced in HFD-fed ATF3 f/f mice to comparable level as HFD-fed ATF3-cKO mice. The biological implication of this finding is not clear. One possibility is that induction of IRS2, a pro-survival gene, by a HFD is an attempt by the cardiac cells to cope with the HFD stress; this adaptation is not necessary in the ATF3-cKO heart, since IRS2 levels are 
for each gene). The results represent the means ± SD (n = 6-8/group). (B)
Immuno-histochemistry analysis of paraformaldehyde fixed heart slices as described in A. Representative nuclear staining is indicated by yellow arrows. already high. The expression levels of other lipid and glycolytic regulators, such as peroxisome proliferator-activated receptor alpha (PPARa), carnitine palmitoyltransferase 1 and 2 (CPT1/2) and pyruvate dehydrogenase kinase 4 (PDK4) were all elevated in HFD-fed mice with no significant difference between the genotypes ( Figure 5A) . Lastly, the level of the glucose transporter 4 (Glut4) were unaffected by both diet and genotype at the mRNA level ( Figure 5A ). However, Glut4 was significantly elevated at the protein level in HFD-fed mice with no significant difference between the genotypes (see Supplementary material online, Figure S4A and B). Collectively, the expression of key metabolic genes was unaltered between the various genotypes in response to HFD. In view of the changes observed in metabolic genes in cardiomyocytes treated with palmitate ( Figure 1A) , this result was unexpected. Thus, we hypothesized that ATF3-dependent alterations in metabolic gene expression in cardiomyocytes may be masked by non-cardiomyocytes cells in the heart. Therefore, we studied the metabolic gene expression changes in isolated cardiomyocytes derived from HFD-and NC-fed mice from both ATF3
f/f and ATF3-cKO mice ( Figure 5B) . Indeed, the expression of all metabolic genes tested was augmented in cardiomyocytes derived from HFD-fed as compared with NC-fed mice. Importantly, the expression level of CD36, CPT1, and CPT2 were significantly upregulated in HFD-fed ATF3-cKO mice as compared with their ATF3 f/f counterparts ( Figure 5B) . In contrast, the induction of both IRS1 and IRS2 were significantly lower in cardiomyocytes derived from HFD-fed ATF3-cKO mice ( Figure 5B) . Collectively, the deleterious effects of HFD on cardiac remodeling, fibrosis and inflammation are more pronounced in ATF3-cKO mice, suggesting that cardiac ATF3 plays a protective role in the HFD paradigm.
HFD-induced cardiac dysfunction
Next, we characterized the effect of HFD and cardiac remodeling on cardiac structure and function in ATF3 f/f and ATF3-cKO mice by echocardiography. Mice fed with NC had normal heart dimensions and fractional shortening (FS) ( Figure 6A and B) . HFD significantly reduced FS in both genotypes of HFD-fed mice as compared to corresponding NCfed mice ( Figure 6B) . However, the reduction was significantly more pronounced in the ATF3-cKO mice, suggesting deteriorated systolic function in these mice ( Figure 6B) . The reduced FS in the HFD-fed ATF3-cKO mice seems to be largely driven by an increase in LV internal endsystolic (LVIDs) dimension ( Figure 6A ). Heart rate was slightly increased in the HFD-fed mice; however, this increase cannot explain the cardiac dysfunction observed in ATF3-cKO mice ( Figure 6B ). In addition, we used cardiac MRI, the gold standard for LV function and mass assessment. 38 LV mass was significantly higher in the ATF3-cKO mice following a 15-week HFD regimen ( Figure 6C ). In addition, end-diastolic and end-systolic volumes were significantly larger in ATF3-cKO mice as compared to ATF3 f/f mice. Moreover, ATF3-cKO mice displayed a significantly lower ejection fraction as compared to ATF3 f/f mice ( Figure 6D ).
These results are consistent with the reduced cardiac function found in the echocardiographic analysis. Images of mid-ventricular short-axis ( Figure 6E ) and long-axis ( Figure 6E ) slices are demonstrating the cardiac eccentric pattern observed in HFD-fed ATF3-cKO mice. Collectively, the results from the MRI show a greater increase in LV mass and volume in the ATF3-cKO mice as compared to the ATF3 f/f mice following a HFD, suggesting fundamental structural differences in the heart between the ATF3-cKO and ATF3 f/f mice.
Impaired glucose tolerance in HFD ATF3-cKO mice
Lastly, we measured fasting glucose levels to assess the diabetic state of the mice. As expected, higher glucose levels were observed in HFD-fed mice as compared to NC-fed counterparts. Interestingly, the hyperglycemia state of the ATF3-cKO mice was significantly higher than in the ATF3 f/f mice following 15 weeks of HFD ( Figure 7A) . Consistently, the glucose tolerance test (GTT) revealed that HFD-fed ATF3-cKO mice displayed higher blood glucose levels and longer glucose clearance time when compared to HFD-fed ATF3
f/f , whereas NC-fed ATF3 f/f and ATF3-cKO mice had normal glucose clearance ( Figure 7B) . Interestingly, whole body ATF3-KO mice fed with HFD also displayed impaired glucose clearance (see Supplementary material online, Figure S5A ). 39 Previously, we reported that decreased glucose tolerance in whole body ATF3-KO mice is, at least in part, due to reduced insulin gene expression in b-cells (see Supplementary material online, Figure  S5B ). 39 To determine insulin level in HFD-fed ATF3-cKO mice, we analysed blood insulin levels by ELISA. In both HFD-fed ATF3 f/f and ATF3-cKO mice the serum insulin levels were significantly higher as compared to their NC-fed counterpart mice, with the ATF3-cKO mice displaying the highest insulin levels ( Figure 7C) . Together, these results suggest that peripheral tissues of ATF3-cKO mice have reduced ability to uptake glucose despite their high insulin level in the blood. Next we sought to measure the protein levels of components along the insulin pathway; Akt and Foxo3. 40 Both Akt, and Foxo3 protein levels were similar in HFD-fed mice independent of the genotype (see Supplementary material online, Figure S4A and C). Interestingly, phosphorylation of Akt, (
) which indicates the activity of the insulin pathway, was slightly elevated in HFD-fed mice; however, this did not reach statistical significance and was similar in both of the genotypes (see Supplementary mate rial online, Figure S4D ). To measure the activity of the insulin signalling pathway following insulin stimulation, we used the ratio between phosphorylated Akt (Ser 473 ) and total Akt expression. HFD-fed mice were injected with insulin (10 U/kg) and the heart, liver and skeletal muscle were harvested 15 min after the injection ( Figure 7D and E and see Supplementary material online, Figure S6A-D) . Insulin injection resulted in a significant increase of pAkt/Akt ratio in the hearts of ATF3 f/f mice, while no significant change was observed in Akt phosphorylation in ATF3-cKO mice ( Figure 7D and E) . Similarly, low Akt phosphorylation f/f and ATF3-cKO mice were fed as described in Figure 2 . mRNA was extracted from ventricles and the expression levels of the indicated inflammatory markers were measured by qRT-PCR. Expression levels are presented as relative values (compared to NC-fed ATF3 f/f mice, determined as 1 for each gene, n= 6-8/group). (B) Mice were fed as described in Figure 2 .
Cardiomyocytes were isolated and primary cultures were generated. mRNA was extracted from an overnight culture and the expression levels of IL-6 and TNFa were studied by qRT-PCR. The mRNA level obtained in cardiomyocytes derived from NC-fed ATF3 f/f mice was determined as 1 and the relative expression of all other treatment is shown (n = 5-6 independent cardiomyocyte preparations). (C) Conditioned media was collected from cardiomyocytes described in B and ELISA assay for the indicated cytokines is shown. Cytokines level is presented as relative values to NC-fed ATF3 f/f mice, determined as 1 for each cytokine (n = 5-6 independent preparations). (D and E) Blood was collected from HFD-fed mice and IL-6 and TNFa serum levels were quantified by ELISA (n = 8-12/group). The results represent the means ± SD. *P < _ 0.05 difference between diets; † P < _ 0.05, difference between genotypes. Figure S6E ). Collectively, our findings revealed a surprising phenomenon that cardiac ATF3 deficiency results in increased cardiac remodeling leading to potentiation of local and peripheral insulin resistance.
Discussion
A HFD is a commonly used regimen to induce T2D. The majority of the literature focuses on diabetic symptoms, without addressing the issue of T2D-induced cardiomyopathy. Even when it is addressed, there is no clear consensus regarding the extent of cardiac effects imposed by HFD. 41 Diet-induced obesity in mouse models is associated with global insulin resistance and increased myocardial fatty acid utilization; however, the reported phenotypes on cardiac function vary from extensive hypertrophy and heart failure 4 to lack of cardiac dysfunction. 42, 43 These variations have been attributed to diet regimens and/or sensitivity of mouse strains to a HFD. In this report, we present evidence that cardiac ATF3 deficiency exacerbates the deleterious effect of a HFD on the heart, such as maladaptive cardiac remodeling, fibrosis, inflammation and cardiac dysfunction. Our work may provide a potential molecular insight to variations in the literature regarding the impact of HFD on the heart. As ATF3 is a stress-inducible gene, we propose that its proper induction in the cardiomyocytes is protective and helps the heart to cope with HFD stress. It is possible that the induction of ATF3-its expression level, duration, and kinetics-varies in different HFD regimens and/or mouse strains, contributing to the variations observed in the literature. HFD regimen induced a significant higher level of fibrosis in the heart of ATF3-cKO mice. We have identified TIMP1 as a possible mechanism to explain the increase in fibrosis in ATF3-cKO cardiomyocytes. Several lines of evidence suggest that TIMP1 is possibly an ATF3 target gene.
First, we observed an increase in TIMP1 transcription in the whole heart and in isolated cardiomyocytes ( Figures 1A and 3A) . Second, TIMP 1, 3 and 4 were identified as significantly highly expressed genes in the heart of ATF3-KO mice as compared with wild type mice following aortic banding. 20 Third, a functional AP-1 regulatory element within the TIMP1 promoter was described. 44 Indeed, preliminary results in our lab suggest that ATF3 downregulates the TIMP1 promoter (data not shown). Thus, it is possible that TIMP1 is suppressed by ATF3 and therefore results in a net increase in MMPs activity that helps to maintain ECM formation/degradation homeostasis.
Our findings are consistent with previous studies demonstrating that a deficiency in ATF3 can promote cardiac maladaptive changes which lead to cardiac dilatation and hypertrophy in an aortic banding model. 19, 20 In contrast, a different study using a pressure overload model reported that ATF3 induces a maladaptive cardiac response. 17 These seemingly conflicting data may be explained by the different patterns of ATF3 expression induced by the different models. In the pressure overload model, the acute and transient expression of ATF3 in cardiomyocytes initiates a cascade of maladaptive changes, 17 whereas in the aortic banding model and the HFD model described here, ATF3 expression is long lasting.
In this context, this is the first report using mice with cardiac-selective deficiency of ATF3 (ATF3-cKO). Previous reports on the roles of ATF3 in cardiac function were carried out using whole body knockout of ATF3 25 or transgenic mice ectopically expressing ATF3 in cardiomyocytes. 16 A key advancement of ATF3-cKO mice over the whole body knockout mice is that they provide insights into the function of ATF3 selectively in cardiomyocytes, without the complication of ATF3 deficiency in other cells. Thus, the ATF3-cKO mouse is a useful tool to better understand the function of cardiac ATF3. Consistent with our previous report, 25 here we showed that cardiac ATF3 deficiency has a more severe HFD-induced diabetic phenotype than the control wild type mice. However, while reduced insulin gene transcription in ATF3-deficient b-cells was observed, 25 our current data
indicates that a lack of insulin is not the explanation for the glucose intolerance found in the HFD-fed ATF3-cKO mice. In contrast, these mice A B Figure 5 HFD-fed ATF3-cKO mice show metabolic response in the heart. ATF3
f/f and ATF3-cKO mice were fed as described in Figure 2 . Figure 7C) . Therefore, upon HFD challenge, cardiac-deficiency of ATF3 exacerbates HFD-induced T2D. This 'peripheral effect' is surprising, since ATF3 is selectively deleted in the cardiomyocytes. The question then is how can we explain the effect of cardiac ATF3 deficiency on peripheral glucose intolerance? One possibility is the reduced IRS1 expression in ATF3-deficient cardiomyocytes, both in vivo and in vitro. IRS1 suppression may lead to impaired insulin signalling in the heart, thereby exacerbating glucose intolerance. Indeed, we observed that HFD-fed ATF3-cKO mice displayed insulin resistance upon insulin challenge when compared to HFD-fed ATF3 f/f mice. In addition, palmitate-treated cardiomyocytes lacking ATF3 displayed lower insulin signalling as compared to their wild type counterparts. Since the heart is only a minor glucose consuming organ in comparison to skeletal muscle cells or the brain, the peripheral systemic effect cannot be solely based on this observation. A case in point, transgenic mice with insulin receptor (IR) deficiency in the heart do not display a diabetic phenotype. 45, 46 Another attractive possibility for the peripheral effect of cardiac ATF3-deletion is its impact on inflammation. It is well established that low-grade inflammation years in advance of the disease onset is involved in the pathogenic processes causing T2D. 8 Mediators of inflammation such as TNFa, interleukin (IL)-1b, the IL-6 family of cytokines, IL-18, and certain chemokines have been proposed to be involved in the events causing both forms of diabetes (T1D and T2D). 8 Interestingly we have shown that, IL-6, a well-known ATF3 target gene 47 is known to enhance its transcription and secretion of cytokines such as IL-6 and TNFa in palmitate-treated primary cultures of ATF3-cKO cardiomyocytes as well as in cardiomyocytes derived from HFD-fed ATF3-cKO mice. IL-6 has been proposed to play a role in glucose homeostasis and metabolism, directly and indirectly via its action on skeletal muscle cells, adipocytes, hepatocytes, pancreatic b-cells, and neuroendocrine cells. 48 Therefore, we hypothesize that elevated levels of inflammatory cytokines in ATF3-cKO mice mediate a cross-talk in peripheral tissues leading to impaired glucose tolerance. Although circulating IL-6 and TNFa cytokines may be derived from different tissues, we provide ample evidence that ATF3-defficient cardiomyocytes produce and secrete higher levels of these cytokines as compared to their wild type counterparts. This indicates a 'cardiac-to-peripheral' effect in T2D-induced cardiomyopathy. This is a reverse direction from the 'peripheral-to-cardiac' effect discussed in the introduction, where inflammation in the peripheral tissues leads to cardiac dysfunction. Since inflammatory cytokines are soluble factors, they can exert a systemic effect. This is why it makes sense that their effect can go both ways. Thus, diabetes and cardiomyopathy are a part of a vicious cycle. Previously it was shown that cardiac specific deletion of the thyroid hormone complex mediator, MED13, results in a peripheral effect upon HFD. Cardiac MED13 deficiency suppresses metabolic genes in the heart which leads to a decrease in energy expenditure and an obese phenotype, most likely, by the secretion of cardiokines that , pAkt) to Akt ratio levels in heart lysate following either saline or insulin injection (10 U/1 kg) is shown. Representative blots (D). Densitometric analysis is presented as means ratio (n = 3-6/group). pAkt/Akt ratio is presented as relative values (compared to HFD-fed saline injected ATF3 f/f mice, determined as 1). *P < _ 0.05, insulin vs. saline treatment; † P < _ 0.05, difference between genotypes (E). mediates the cross talk between the heart and peripheral tissues.
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Here we also observed increased levels of natriuretic peptides (ANP and BNP) which together with IL-6 and TNFa may mediate the cross-talk with the peripheral tissues to induce glucose intolerance. Does this finding have any relevance to cardiac disease in humans? Several lines of evidence suggests that congestive heart failure in patients is associated with an increase in blood glucose levels. 52 In addition, high blood glucose levels in non-diabetic patients with acute myocardial infarction, serves as a prognostic predictor of long-term mortality. 53, 54 Thus, here we provide evidence that high blood glucose levels are a part of the symptoms of cardiac remodeling process. Collectively, our findings suggest that cardiac ATF3 expression is responsible for an adaptive cardiac response to the stressful environment under a HFD (Figure 8) . ATF3 dampens the inflammatory response and suppresses the expression of ECM remodeling genes and thus ameliorates cardiac function. In HFD-fed mice with ATF3 deficiency or in mice with cardiac remodeling, the inflamed heart affects also peripheral tissues, thereby worsening T2D in peripheral tissues resulting in elevated blood glucose level and turning on a vicious cycle to worsen cardiomyopathy.
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Supplementary material is available at Cardiovascular Research online. homeostasis following HFD-induced T2D. In contrast, stressful environment under HFD leads to maladaptive cardiac response in the absence of ATF3. Cardiac remodeling caused by ATF3 deficiency induces an increase in cardiac, ECM remodeling and inflammatory genes and mediates the communication of cardiomyocytes with heart resident cells, potentially mediated by IL-6, TNFa, ANP, BNP and TIMP1. In this situation, increased cardiac fibrosis and inflammatory response worsen cardiac function. The inflamed failing heart mediates the communication of cardiomyocytes with distant organs as well thereby affecting diabetic outcome and glucose homeostasis.
ATF3 expression in cardiomyocytes preserves homeostasis
